Current controlled trials in cardiovascular medicine / / BioMed Central, PubMed Central |
Pubbl/distr/stampa | [London], : BioMed Central, 2000-2005 |
Descrizione fisica | 1 online resource |
Disciplina | 616 |
Soggetto topico |
Cardiology
Clinical trials Cardiovascular Diseases - therapy Cardiovascular Diseases - physiopathology |
Soggetto genere / forma |
Periodicals.
Controlled Clinical Trial |
Soggetto non controllato | Cardiovascular Diseases |
ISSN | 1468-6694 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Nota di contenuto | Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT. |
Altri titoli varianti | CCTCVM |
Record Nr. | UNISA-996204820603316 |
[London], : BioMed Central, 2000-2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Current controlled trials in cardiovascular medicine / / BioMed Central, PubMed Central |
Pubbl/distr/stampa | [London], : BioMed Central, 2000-2005 |
Descrizione fisica | 1 online resource |
Disciplina | 616 |
Soggetto topico |
Cardiology
Clinical trials Cardiovascular Diseases - therapy Cardiovascular Diseases - physiopathology |
Soggetto genere / forma |
Periodicals.
Controlled Clinical Trial |
Soggetto non controllato | Cardiovascular Diseases |
ISSN | 1468-6694 |
Formato | Materiale a stampa |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Nota di contenuto | Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins -- Comments on ALLHAT and doxazosin -- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? -- Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight -- Debate: PCI vs CABG: a moving target, but we are gaining -- Debate: Should statin be used in patients with heart failure? -- Debate: Statins should be used in patients with heart failure -- Cytokines as new treatment targets in chronic heart failure -- Therapeutic angiogenesis for cardiovascular disease -- Distal protection devices during percutaneous coronary and carotid interventions -- Biventricular pacing in heart failure: update on results from clinical trials -- How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2) -- A new era in hypertension research: discussing the findings of ALLHAT. |
Altri titoli varianti | CCTCVM |
Record Nr. | UNINA-9910134113603321 |
[London], : BioMed Central, 2000-2005 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|